Ocular Therapeutix, Inc. (OCUL)
6.205
-0.08
(-1.19%)
USD |
NASDAQ |
Nov 13, 16:00
6.20
0.00 (0.00%)
After-Hours: 19:59
Ocular Therapeutix Market Cap : 1.364B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.381B |
| November 11, 2026 | 1.464B |
| November 10, 2026 | 1.453B |
| November 09, 2026 | 1.506B |
| November 06, 2026 | 1.450B |
| November 05, 2026 | 1.414B |
| November 04, 2026 | 1.568B |
| November 03, 2026 | 1.498B |
| November 02, 2026 | 1.478B |
| October 30, 2026 | 1.531B |
| October 29, 2026 | 1.605B |
| October 28, 2026 | 1.601B |
| October 27, 2026 | 1.476B |
| October 26, 2026 | 1.421B |
| October 23, 2026 | 1.427B |
| October 22, 2026 | 1.451B |
| October 21, 2026 | 1.423B |
| October 20, 2026 | 1.460B |
| October 19, 2026 | 1.381B |
| October 16, 2026 | 1.509B |
| October 15, 2026 | 1.621B |
| October 14, 2026 | 1.581B |
| October 13, 2026 | 1.590B |
| October 12, 2026 | 1.660B |
| October 09, 2026 | 1.656B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.649B |
| October 07, 2026 | 1.588B |
| October 06, 2026 | 1.612B |
| October 05, 2026 | 1.592B |
| October 02, 2026 | 1.528B |
| October 01, 2026 | 1.601B |
| September 30, 2026 | 1.684B |
| September 29, 2026 | 1.728B |
| September 28, 2026 | 1.681B |
| September 25, 2026 | 2.119B |
| September 24, 2026 | 2.156B |
| September 23, 2026 | 2.196B |
| September 22, 2026 | 2.306B |
| September 21, 2026 | 2.194B |
| September 18, 2026 | 2.194B |
| September 17, 2026 | 2.227B |
| September 16, 2026 | 2.167B |
| September 15, 2026 | 2.238B |
| September 14, 2026 | 2.354B |
| September 11, 2026 | 2.303B |
| September 10, 2026 | 2.332B |
| September 09, 2026 | 2.519B |
| September 08, 2026 | 2.497B |
| September 04, 2026 | 2.336B |
| September 03, 2026 | 2.336B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| EyePoint, Inc. | 26.34M |
| ANI Pharmaceuticals, Inc. | 1.637B |
| Eli Lilly & Co. | 1.360T |
| Corcept Therapeutics, Inc. | 7.979B |
| Veru, Inc. | 36.15M |
Market Cap Related Metrics
| PS Ratio | 27.63 |
| PEG Ratio | -3.156 |
| Price to Book Value | 3.094 |
| Price | 6.205 |
| Earnings Yield | -23.46% |
| PEGY Ratio | -3.156 |